ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours (Q37452750)
Jump to navigation
Jump to search
scientific article published on 21 October 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours |
scientific article published on 21 October 2016 |
Statements
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours (English)
Fay H Cafferty
Samuel Rowley
Mairead MacKenzie
Lindy Berkman
Sudeep Gupta
C S Pramesh
Duncan Gilbert
Howard Kynaston
David Cameron
Richard H Wilson
Alistair Ring
Ruth E Langley
Add-Aspirin investigators
1 reference
1 reference
1 reference